Member access

4-Traders Homepage  >  Shares  >  Euronext Bruxelles  >  UCB    UCB   BE0003739530

UCB

 (UCB)
222
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   Delayed Quote. Delayed Euronext Bruxelles
06/13/2013 06/14/2013 06/17/2013 06/18/2013 06/19/2013 Date
39.93(c) 40.1(c) 39.8(c) 39.6(c) 39.465 Last
270 205 343 649 166 832 123 060 257 997 Volume
-0.10% +0.43% -0.75% -0.50% -0.34% Change
More quotes
Company
UCB is a biopharmaceutical company focused on the discovery and the development of innovative medicines in the fields of central nervous system and immunology disorders. Net sales break down by activity as follows: - sales of bio-pharmaceutical products (88.7%): for treating central nervous system... 
Read more
Surperformance© rating of UCB
Trading Rating : Investor Rating :
More about the company
Chart UCB
Duration : Period :
UCB Technical Analysis Chart | UCB | BE0003739530 | 4-Traders
Full-screen chart
Financials (€)
Sales 2013 3 448 M
EBIT 2013 501 M
Net income 2013 255 M
Debt 2013 1 725 M
Yield 2013 2,61%
Sales 2014 3 645 M
EBIT 2014 609 M
Net income 2014 326 M
Debt 2014 1 483 M
Yield 2014 2,78%
PER 2013 27,69
PER 2014 20,81
EV / Sales 2013 2,61x
EV / Sales 2014 2,40x
Capitalization 7 264 M
More Financials
Latest news on UCB
5d ago UCB: Update on share capital, securities carrying voting rights and voting righ..
6d ago UCB: announces new results from phase 2b open-label extension study evaluating ..
06/12 UCB: Transparency notification of Vanguard Health Care Fund
06/11 UCB: to collaborate with CRELUX and 4SC Discovery to meet unmet needs in neurol..
05/29 UCB: to secure long-term partnership with UNITHER Pharmaceuticals for its Roche..
05/24 UCB: Transparency notification of The Capital Group Companies Inc.
05/16 UCB: and IBM Collaborate to Personalize Care for Epilepsy Patients
05/09 UCB: Acquisition of own shares (09 05)
05/02 UCB: ex-dividend day for annual dividend
04/25 UCB: UCB's shareholder meeting today
04/25 UCB: Slow Start but Outlook 2013 and Growth Prospects Confirmed
04/22UCB SA: quaterly earnings release
More news
Forum UCB
Be the first to post a message on UCB
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
UCB : Income Statement Evolution
More Financials
EPS Revisions
UCB : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.